Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Outcome of pulmonary metastasectomy of colorectal cancer followed by adjuvant chemotherapy according to the prognostic index: A subset analysis of prospective multicenter study

ABSTRACT: Primary outcome(s): Evaluation of the ability and reproducibility of risk classification by the prognostic index.

DISEASE(S): Colorectal Cancer

PROVIDER: 2740896 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Outcomes and prognostic factors of repeat pulmonary metastasectomy.

Project description: Not available

| S-EPMC10927334 | biostudies-literature

The histologic effects of neoadjuvant stereotactic body radiation therapy (SBRT) followed by pulmonary metastasectomy-rationale and protocol design for the Post SBRT Pulmonary Metastasectomy (PSPM) trial.

Project description: Not available

| S-EPMC9091013 | biostudies-literature

A Prognostic Gene Expression Index in Ovarian Cancer

Project description:Ovarian carcinoma has the highest mortality rate among gynecological malignancies. In this project, we investigated the hypothesis that molecular markers are able to predict outcome of ovarian cancer independently of classical clinical predictors, and that these molecular markers can be validated using independent data sets. We applied a semi-supervised method for prediction of patient survival. Microarrays from a cohort of 80 ovarian carcinomas (TOC cohort) were used for the development of a predictive model, which was then evaluated in an entirely independent cohort of 118 carcinomas (Duke cohort). A 300 gene ovarian prognostic index (OPI) was generated and validated in a leave-one-out approach in the TOC cohort (Kaplan-Meier analysis, p=0.0087). In a second validation step the prognostic power of the OPI was confirmed in an independent data set (Duke cohort, p=0.0063). In multivariate analysis, the OPI was independent of the postoperative residual tumour, the main clinico-pathological prognostic parameter with an adjusted hazard ratio of 6.4 (TOC cohort, CI 1.8 – 23.5, p=0.0049) and 1.9 (Duke cohort, CI 1.2 – 3.0, p=0.0068). We constructed a combined score of molecular data (OPI) and clinical parameters (residual tumour), which was able to define patient groups with highly significant differences in survival. The integrated analysis of gene expression data as well as residual tumour can be used for optimised assessment of prognosis. As traditional treatment options are limited, this analysis may be able to optimise clinical management and to identify those patients that would be candidates for new therapeutic strategies. Keywords: disease state analysis

2009-02-09 | GSE14764 | GEO

A Prognostic Gene Expression Index in Ovarian Cancer

2009-02-09 | E-GEOD-14764 | biostudies-arrayexpress

Lymphadenectomy in pulmonary metastasectomy.

Project description: Not available

| S-EPMC8107571 | biostudies-literature

Integrative molecular and clinical analysis of intrahepatic cholangiocarcinoma reveals two prognostic subclassees

Project description:Intrahepatic cholangiocarcioma has two molecular classification of intrahepatic CCA with distinct clinical, pathological, biological and prognostic differences

2018-12-01 | GSE107943 | GEO

Pulmonary metastasectomy: limits to credibility.

Project description: Not available

| S-EPMC8107549 | biostudies-literature

Results of redo pulmonary metastasectomy.

Project description: Not available

| S-EPMC8107525 | biostudies-literature

Pulmonary metastasectomy in colorectal carcinoma.

Project description: Not available

| S-EPMC8107514 | biostudies-literature

Prognostic Impact of Pulmonary Metastasectomy for Uterine Malignancies: A Retrospective Analysis of 38 Cases.

Project description: Not available